Blue Water Vaccines (BWV) Announces Collaboration with Instituto Butantan for the Development of BWV-101, a Universal Influenza Vaccine Candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/26/2026

1. INTC
2. DECK
3. AMD
4. META
5. INFY
6. RNG
7. TMUS
8. SPY
9. UNP
10. GOOGL

Go back to Blue Water Vaccines (BWV) Announces Collaboration with Instituto Butantan for the Development of BWV-101, a Universal Influenza Vaccine Candidate

Blue Water Vaccines Announces Collaboration with Instituto Butantan for the Development of BWV-101, a Universal Influenza Vaccine Candidate

May 19, 2022 2:00 PM EDT

CINCINNATI, May 19, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. (BWV or Blue Water Vaccines or the Company) a biopharmaceutical company developing vaccines, announces a collaboration with the multidisciplinary Center for R&D in Immunobiologics (CeRDI), an initiative of Instituto Butantan (Butantan). Through this partnership, Butantan, a leading Brazilian producer of immunobiologic products and vaccines, and BWV will develop the universal influenza vaccine candidate, BWV-101, in Brazil.

Instituto Butantan was approved for a grant from The State of Sao Paulo Research Foundation (FAPESP) to develop BWVs universal influenza vaccine candidate in Brazil. This project grant is part of a larger consortium across... More